With a market cap of a miniscule $10.16 million, you can firmly place biotech Capricor Therapeutics (CAPR) in the nano cap section.
Gilead Sciences (GILD) has positioned itself at the front line in the global war against COVID-19. The biotech’s experimental drug remdesivir is currently …
Every time a door shuts, another window of opportunity opens, the old saying sort of goes. At least that is how one analyst …
“To say the world has completely changed over the last 1-2 months in the wake of the COVID-19 pandemic is an understatement,” says …
Last month, the S&P 500 hit bottom at 2,237 (it touched 2,192 in intraday trading) and has staged a mild rally since. The …
It’s a new week, and market watchers are bracing themselves for whatever comes their way. Ahead of the opening bell on Monday U.
Canadian investment bank RBC has been taking the temperature of institutional investors, and the results are fascinating – and, perhaps, illuminating. The analysts start …
Almost three months have passed since COVID-19 began its spread beyond China’s borders, and the market remains in free fall. Capping off another volatile week, stocks fell on Friday April 3 in response …
Anyone need a Lyft (LYFT)? It’s funny how such an ordinary question appears so out of place, but it is only a reflection …
The trailing twelve-month chart for freelancing platform Upwork (UPWK) makes for queasy viewing. The stock has declined by 73%, 50% of which were …
